Tin Oxide Nanowires Suppress Herpes Simplex Virus-1 Entry and Cell-to-Cell Membrane Fusion

The advent of nanotechnology has ushered in the use of modified nanoparticles as potential antiviral agents against diseases such as herpes simplex virus 1 and 2 (HSV-1) (HSV-2), human immunodeficiency virus (HIV), monkeypox virus, and hepatitis B virus. Here we describe the application of tin oxide (SnO2) nanowires as an effective treatment against HSV-1 infection. SnO2 nanowires work as a carrier of negatively charged structures that compete with HSV-1 attachment to cell bound heparan sulfate (HS), therefore inhibiting entry and subsequent cell-to-cell spread. This promising new approach can be developed into a novel form of broad-spectrum antiviral therapy especially since HS has been shown to serve as a cellular co-receptor for a number of other viruses as well, including the respiratory syncytial virus, adeno-associated virus type 2, and human papilloma virus.

[1]  Erika Maus,et al.  Role of heparan sulfate in sexually transmitted infections. , 2012, Glycobiology.

[2]  Yogendra Kumar Mishra,et al.  Aerographite: Ultra Lightweight, Flexible Nanowall, Carbon Microtube Material with Outstanding Mechanical Performance , 2012, Advanced materials.

[3]  D. Shukla,et al.  Early Events in Herpes Simplex Virus Lifecycle with Implications for an Infection of Lifetime , 2012, The open virology journal.

[4]  R. Adelung,et al.  Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1. , 2011, Antiviral research.

[5]  D. Shukla,et al.  Herpes simplex virus infects most cell types in vitro: clues to its success , 2011, Virology Journal.

[6]  A. Gurlo,et al.  Nanosensors: towards morphological control of gas sensing activity. SnO2, In2O3, ZnO and WO3 case studies. , 2011, Nanoscale.

[7]  R. Sarid,et al.  Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles. , 2010, Small.

[8]  D. Shukla,et al.  An unusual dependence of human herpesvirus-8 glycoproteins-induced cell-to-cell fusion on heparan sulfate. , 2009, Biochemical and biophysical research communications.

[9]  D. Shukla,et al.  A Novel Function of Heparan Sulfate in the Regulation of Cell-Cell Fusion* , 2009, The Journal of Biological Chemistry.

[10]  Sourabh Shukla,et al.  Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. , 2009, Bioconjugate chemistry.

[11]  Andrés Legarra,et al.  Performance of Genomic Selection in Mice , 2008, Genetics.

[12]  K. Kitazato,et al.  Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA , 2008, Archives of Virology.

[13]  D. Knipe,et al.  Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease. , 2007, Virology.

[14]  B. Yue,et al.  A novel role for phagocytosis-like uptake in herpes simplex virus entry , 2006, The Journal of cell biology.

[15]  N. Novak,et al.  Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells , 2005, Clinical and experimental immunology.

[16]  B. Yue,et al.  A Role for Herpesvirus Entry Mediator as the Receptor for Herpes Simplex Virus 1 Entry into Primary Human Trabecular Meshwork Cells , 2005, Journal of Virology.

[17]  Jian Liu,et al.  A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1. , 2004, The Journal of general virology.

[18]  P. Dubreuil,et al.  Cell-to-Cell Spread of Wild-Type Herpes Simplex Virus Type 1, but Not of Syncytial Strains, Is Mediated by the Immunoglobulin-Like Receptors That Mediate Virion Entry, Nectin1 (PRR1/HveC/HIgR) and Nectin2 (PRR2/HveB) , 2000, Journal of Virology.

[19]  R. Eisenberg,et al.  A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry , 1999, Cell.

[20]  P. Desai,et al.  Incorporation of the Green Fluorescent Protein into the Herpes Simplex Virus Type 1 Capsid , 1998, Journal of Virology.

[21]  R. Roller,et al.  Characterization of a BHK(TK-) cell clone resistant to postattachment entry by herpes simplex virus types 1 and 2 , 1997, Journal of virology.

[22]  H. Handa,et al.  An SV40-immortalized human corneal epithelial cell line and its characterization. , 1995, Investigative ophthalmology & visual science.

[23]  B. Herold,et al.  Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity , 1991, Journal of virology.

[24]  P. Spear,et al.  Initial interaction of herpes simplex virus with cells is binding to heparan sulfate , 1989, Journal of virology.